AIM ImmunoTech Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AIM American 2834 http://www.hemispherx.net/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AIM ImmunoTech Inc

AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020 - Dec 4th, 2019 11:30 am
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019 - Nov 15th, 2019 3:25 pm
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019 - Nov 15th, 2019 11:30 am
AIM ImmunoTech to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference - Oct 23rd, 2019 10:30 am
AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points Identified - Oct 7th, 2019 10:30 am
AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering - Sep 25th, 2019 1:50 pm
AIM ImmunoTech Inc. Announces a Second DoD Award, This One of $8.3 Million, to Fund Phase 2 Clinical Trial to Study Ampligen as Part of a New Treatment for Brain-Metastatic Breast Cancer at the Moffitt Cancer Center - Sep 24th, 2019 10:30 am
AIM ImmunoTech’s Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syndrome - Sep 24th, 2019 10:00 am
AIM ImmunoTech Shares Spike Up 90% After $6.42M 'Breakthrough Award' - Sep 19th, 2019 12:43 pm
AIM ImmunoTech Inc. Announces the U.S. Department of Defense’s Award of $6.42M to Roswell Park Comprehensive Cancer Center to Study Ampligen as Part of a New Treatment of Brain-Metastatic Breast Cancer - Sep 19th, 2019 10:50 am
AIM ImmunoTech Names Ellen Lintal as New Chief Financial Officer - Sep 16th, 2019 10:50 am
AIM ImmunoTech Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City - Sep 13th, 2019 10:50 am
AIM ImmunoTech Announces Progress Toward Opening of Breast Cancer Study at Roswell Park Comprehensive Cancer Center - Sep 10th, 2019 11:30 am
AIM ImmunoTech Inc. Announces its Name Change is Complete, Its New Website is Up and the Company Now Trades as Ticker Symbol 'AIM' - Sep 9th, 2019 11:45 am
AIM ImmunoTech to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 10th - Sep 6th, 2019 10:30 am